Natalizumab induces and maintains continuous response and remission in patients with active Crohn's disease despite prior anti-tumor necrosis factor-alpha treatment

R Panaccione; J Colombel; R Enns; B Feagan; S Hanauer; Ian Lawrance; P Rutgeerts; W Sandborn; S Schreiber; S Targan; S Van Deventer

Natalizumab induces and maintains continuous response and remission in patients with active Crohn's disease despite prior anti-tumor necrosis factor-alpha treatment

R Panaccione, J Colombel, R Enns, B Feagan, S Hanauer, Ian Lawrance, P Rutgeerts, W Sandborn, S Schreiber, S Targan, S Van Deventer

Research output: Chapter in Book/Conference paper › Conference paper

1 Citation (Web of Science)

Original language	English
Title of host publication	INFLAMMATORY BOWEL DISEASES
Pages	S10-S10
Volume	14
Publication status	Published - 2008
Event	Natalizumab induces and maintains continuous response and remission in patients with active Crohn's disease despite prior anti-tumor necrosis factor-alpha treatment - Duration: 1 Jan 2008 → …

Conference

Conference	Natalizumab induces and maintains continuous response and remission in patients with active Crohn's disease despite prior anti-tumor necrosis factor-alpha treatment
Period	1/01/08 → …

Cite this

Panaccione, R., Colombel, J., Enns, R., Feagan, B., Hanauer, S., Lawrance, I., Rutgeerts, P., Sandborn, W., Schreiber, S., Targan, S., & Van Deventer, S. (2008). Natalizumab induces and maintains continuous response and remission in patients with active Crohn's disease despite prior anti-tumor necrosis factor-alpha treatment. In INFLAMMATORY BOWEL DISEASES (Vol. 14, pp. S10-S10)

@inproceedings{a2519b2983a048c18feeb061a9e03bf2,

title = "Natalizumab induces and maintains continuous response and remission in patients with active Crohn's disease despite prior anti-tumor necrosis factor-alpha treatment",

author = "R Panaccione and J Colombel and R Enns and B Feagan and S Hanauer and Ian Lawrance and P Rutgeerts and W Sandborn and S Schreiber and S Targan and {Van Deventer}, S",

year = "2008",

language = "English",

volume = "14",

pages = "S10--S10",

booktitle = "INFLAMMATORY BOWEL DISEASES",

note = "Natalizumab induces and maintains continuous response and remission in patients with active Crohn's disease despite prior anti-tumor necrosis factor-alpha treatment ; Conference date: 01-01-2008",

}

Panaccione, R, Colombel, J, Enns, R, Feagan, B, Hanauer, S, Lawrance, I, Rutgeerts, P, Sandborn, W, Schreiber, S, Targan, S & Van Deventer, S 2008, Natalizumab induces and maintains continuous response and remission in patients with active Crohn's disease despite prior anti-tumor necrosis factor-alpha treatment. in INFLAMMATORY BOWEL DISEASES. vol. 14, pp. S10-S10, Natalizumab induces and maintains continuous response and remission in patients with active Crohn's disease despite prior anti-tumor necrosis factor-alpha treatment, 1/01/08.

TY - GEN

T1 - Natalizumab induces and maintains continuous response and remission in patients with active Crohn's disease despite prior anti-tumor necrosis factor-alpha treatment

AU - Panaccione, R

AU - Colombel, J

AU - Enns, R

AU - Feagan, B

AU - Hanauer, S

AU - Lawrance, Ian

AU - Rutgeerts, P

AU - Sandborn, W

AU - Schreiber, S

AU - Targan, S

AU - Van Deventer, S

PY - 2008

Y1 - 2008

M3 - Conference paper

VL - 14

SP - S10-S10

BT - INFLAMMATORY BOWEL DISEASES

T2 - Natalizumab induces and maintains continuous response and remission in patients with active Crohn's disease despite prior anti-tumor necrosis factor-alpha treatment

Y2 - 1 January 2008

ER -